1. Home
  2. WRBY vs EVO Comparison

WRBY vs EVO Comparison

Compare WRBY & EVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Warby Parker Inc.

WRBY

Warby Parker Inc.

HOLD

Current Price

$22.61

Market Cap

2.1B

Sector

Health Care

ML Signal

HOLD

Logo Evotec SE

EVO

Evotec SE

HOLD

Current Price

$3.20

Market Cap

1.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
WRBY
EVO
Founded
2010
1993
Country
United States
Germany
Employees
N/A
N/A
Industry
Ophthalmic Goods
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.1B
1.1B
IPO Year
2021
2021

Fundamental Metrics

Financial Performance
Metric
WRBY
EVO
Price
$22.61
$3.20
Analyst Decision
Buy
Strong Buy
Analyst Count
15
1
Target Price
$25.43
$7.00
AVG Volume (30 Days)
6.1M
250.0K
Earning Date
11-06-2025
11-05-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.00
N/A
Revenue
$850,580,000.00
$887,396,457.00
Revenue This Year
$15.47
N/A
Revenue Next Year
$13.06
$8.52
P/E Ratio
$3,854.07
N/A
Revenue Growth
14.55
N/A
52 Week Low
$13.63
$2.84
52 Week High
$31.00
$4.80

Technical Indicators

Market Signals
Indicator
WRBY
EVO
Relative Strength Index (RSI) 46.95 54.56
Support Level $21.46 $3.08
Resistance Level $27.29 $3.18
Average True Range (ATR) 1.42 0.08
MACD -0.66 0.03
Stochastic Oscillator 13.90 92.31

Price Performance

Historical Comparison
WRBY
EVO

About WRBY Warby Parker Inc.

Warby Parker Inc is a mission-driven, lifestyle brand that operates at the intersection of design, technology, healthcare, and social enterprise. The company predominantly derives revenue from the sales of eyewear products, optical services, and accessories. The firm sells products and services through its stores, website, and mobile apps. Revenue generated from eyewear products includes the sales of prescription and non-prescription optical glasses and sunglasses, contact lenses, eyewear accessories, and expedited shipping charges.

About EVO Evotec SE

Evotec is a drug discovery partnership firm providing solutions to pharmaceutical and biotechnology companies, academic institutions, foundations, and nonprofit organizations. The company offers services in a variety of therapeutic areas, including central nervous system disorders, diabetes, inflammation, oncology, infectious diseases, and women's health. The shared R&D segment, roughly 80% of sales, provides drug discovery and manufacturing services on a typical fee-for-service basis and integrated drug discovery collaborations based on its proprietary, internally developed assets. The Just-Evotec Biologics segment, about 20% of sales, offers CDMO services for biologics. As of 2023, the company has over 5,000 employees and 18 production sites mainly in Europe and the United States.

Share on Social Networks: